Conversely, uncontrolled intracellular C3 activation and CD46 signalling leads to the dysregulation of human T cell responses and contributes to pathologically hyperactive TH1 cells in autoimmune disease (e.g., rheumatoid arthritis (RA)) (11, 15). This evidence concerns the gene CD46 and rheumatoid arthritis.